Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048),…
Partnership provides virtual clinical support with data driven measurement to improve adherence for obesity management MIAMI, May 5, 2025 /PRNewswire/ -- eMed®, the leading Population Health technology…
In a featured conversation with social psychologist and author Jonathan Haidt, First Partner Jennifer Siebel Newsom today announced a new…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Acquisition--Netsmart, an industry-leading provider of healthcare IT for human services and post-acute care, announces its participation at…
Our Rescue, Mental Health Tech Company and First Nations Advocate Unite to Raise Awareness and Funds for Trafficking Survivors MINNEAPOLIS,…
NEW YORK, May 5, 2025 /PRNewswire/ -- Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in…
Seasoned pharmaceutical executive to advise on clinical development, regulatory strategy, and commercialization as Company accelerates its psilocybin-based therapeutic programs BOSTON,…
The Company is now recognized by the U.S. FDA to support the cross-border supply of GMP MDMA and psilocybin to…
Gut transformation through Bioma a perfectly blended combination of probiotics prebiotics and postbiotics Bioma Bioma New York City, May 03,…
Sober.Buzz the Sober Token spreading the good $BUZZ! Sober.Buzz is the cryptocurrency being developed by alcoholics and addicts in recovery…